PENG and LFCN Block Versus FIC Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis Focused on Movement (Retro-PvF)
Retro-PvF
Pericapsular Nerve Group (PENG) Block and Lateral Femoral Cutaneous Nerve (LFCN) Block Versus Fascia Iliaca (FIC) Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis Focused on Movement (Retro- PvF)
1 other identifier
observational
80
1 country
1
Brief Summary
Total hip arthroplasty is a major surgical procedure performed on a growing number of patients. Optimal pain control with limited muscle weakness is paramount for a swift initiation of physical therapy and ambulation, thus expediting hospital discharge. Amongst the many peripheral nerve blocks, FIB (fascia iliaca block) has been recommended as the block of choice by many international guidelines since it offers the best pain control with a relatively low risk of motor block. PENG (pericapsular nerve group) and its association with LFCN (lateral femoral cutaneous nerve) has been proposed as an effective alternative that offers comparable, If not better, pain control with a considerably lower risk for motor block compared to FIB. Given the novelty of this block, there are few published papers on the subject, mostly case series or case reports thus justifying the need for retrospective study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2024
CompletedStudy Start
First participant enrolled
March 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedMarch 19, 2025
March 1, 2025
6 days
March 26, 2024
March 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Movement of the lower limb affected by surgery
The Medical Research Council (MRC) Muscle Strength Scale (ranging scale from 0 to 5 0= no visible contraction, 5=normal power) was used to assess the degree of residual quadriceps femoris muscle paresis 6 hours postoperatively.
6 hours after surgery
Secondary Outcomes (6)
pain control
6 hours after surgery
pain control
12 hours after surgery
pain control
24 hours after surgery
Morphine Milligram Equivalents (MME) of "pro re nata" (PRN) opioid doses
24 hours after surgery
Morphine Milligram Equivalents (MME) of "pro re nata" (PRN) opioid doses
6 hours after surgery
- +1 more secondary outcomes
Other Outcomes (2)
time to first opioid request
From date of surgery until up to 3 days after
time to first postoperative ambulation
From date of surgery until up to 3 days after
Study Arms (2)
PENG + LFCN Block
group in which PENG + LFCN Block was performed
FIC Block
group in which FIC Block was performed
Interventions
The PENG block was performed under ultrasound guidance. After skin disinfection, the needle was advanced between the psoas tendon and pubic ramus where 20 mL of 0.5% ropivacaine were injected. The LFCN block was performed following the PENG block.10 ml of 0.5% ropivacaine were injected near the nerve into the fat-filled flat tunnel (FFFT) located at the level of the superior anterior iliac spine and lateral to the sartorius muscle.
FICB was performed under ultrasound guidance. The needle was advanced above the fascia iliaca and 20 mL of 0.5% ropivacaine were injected
Eligibility Criteria
Historical cohort study conducted among all patients who had THA from November 2022 to October 2023 at the ASST Nord Milano - Bassini Hospital, Cinisello Balsamo, Milano, Italy.
You may qualify if:
- elective total hip replacement surgery for non-traumatic hip disease,
- age over 18 years,
- complete clinical chart including type of peripheral nerve block performed,
- signed consent form for spinal anesthesia and peripheral nerve block.
You may not qualify if:
- preoperative opioid therapy,
- having received a peripheral nerve block other than PENG + LFCN or FICB,
- having received general anesthesia,
- incomplete chart,
- documented muscle weakness
- deviation from the established post-operative analgesia protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ASST Nord Milano - Ospedale E. Bassini
Cinisello Balsamo, Italy/Milano, 20092, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 2, 2024
Study Start
March 26, 2024
Primary Completion
April 1, 2024
Study Completion
April 30, 2024
Last Updated
March 19, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share